Bloomage Interest Income vs Ebit Analysis

688363 Stock

48.35 1.05 2.13%

Bloomage Biotechnology financial indicator trend analysis is way more than just evaluating Bloomage Biotechnology prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bloomage Biotechnology is a good investment. Please check the relationship between Bloomage Biotechnology Interest Income and its Ebit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Interest Income vs Ebit

Interest Income vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bloomage Biotechnology Interest Income account and Ebit. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Bloomage Biotechnology's Interest Income and Ebit is 0.9. Overlapping area represents the amount of variation of Interest Income that can explain the historical movement of Ebit in the same time period over historical financial statements of Bloomage Biotechnology Corp, assuming nothing else is changed. The correlation between historical values of Bloomage Biotechnology's Interest Income and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Income of Bloomage Biotechnology Corp are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Interest Income i.e., Bloomage Biotechnology's Interest Income and Ebit go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Ebit

Most indicators from Bloomage Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bloomage Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 3.6 B, whereas Tax Provision is forecasted to decline to about 117.2 M.

	2022	2023	2024	2025 (projected)
Gross Profit	4.9B	4.5B	5.1B	2.6B
Total Revenue	6.4B	6.1B	7.0B	7.3B

Gross Profit Total Revenue

Bloomage Biotechnology fundamental ratios Correlations

	Other Liab	Net Tangible Assets	Retained Earnings	Other Assets	Other Stockholder Equity	Common Stock	Property Plant Equipment	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Good Will
Other Liab		0.89	0.92	0.9	-0.78	0.82	0.98	0.92	0.07	0.84	0.91	0.88	0.67	0.95	0.51	0.88	0.89	0.94	0.35	0.86	0.96	-0.27	0.85	-0.8	0.91	0.81
Net Tangible Assets	0.89		0.77	0.81	-0.74	0.9	0.87	0.99	0.11	0.87	1.0	0.77	0.81	0.83	0.47	0.98	0.88	0.85	0.38	0.88	0.92	-0.29	0.94	-0.78	0.99	0.68
Retained Earnings	0.92	0.77		0.87	-0.59	0.59	0.95	0.83	-0.24	0.81	0.81	0.96	0.45	0.98	0.55	0.83	0.79	0.97	0.06	0.81	0.9	0.03	0.65	-0.59	0.76	0.94
Other Assets	0.9	0.81	0.87		-0.44	0.63	0.93	0.86	0.04	0.83	0.84	0.83	0.58	0.9	0.61	0.82	0.83	0.9	0.41	0.84	0.87	-0.03	0.77	-0.55	0.82	0.76
Other Stockholder Equity	-0.78	-0.74	-0.59	-0.44		-0.85	-0.67	-0.7	-0.16	-0.54	-0.72	-0.56	-0.65	-0.62	-0.14	-0.68	-0.64	-0.63	-0.32	-0.56	-0.73	0.61	-0.74	0.89	-0.75	-0.5
Common Stock	0.82	0.9	0.59	0.63	-0.85		0.75	0.87	0.23	0.68	0.89	0.61	0.85	0.69	0.19	0.83	0.75	0.71	0.44	0.7	0.84	-0.57	0.9	-0.89	0.93	0.53
Property Plant Equipment	0.98	0.87	0.95	0.93	-0.67	0.75		0.92	0.01	0.9	0.9	0.92	0.65	0.98	0.6	0.89	0.91	0.98	0.22	0.9	0.97	-0.11	0.82	-0.69	0.88	0.85
Total Assets	0.92	0.99	0.83	0.86	-0.7	0.87	0.92		0.06	0.92	1.0	0.84	0.77	0.88	0.55	0.98	0.92	0.9	0.31	0.92	0.94	-0.2	0.92	-0.74	0.98	0.75
Other Current Liab	0.07	0.11	-0.24	0.04	-0.16	0.23	0.01	0.06		0.07	0.05	-0.36	0.34	-0.17	0.08	-0.03	0.26	-0.2	0.49	0.11	0.05	-0.47	0.27	-0.18	0.15	-0.5
Total Current Liabilities	0.84	0.87	0.81	0.83	-0.54	0.68	0.9	0.92	0.07		0.88	0.84	0.61	0.84	0.81	0.85	0.97	0.86	0.13	1.0	0.86	0.1	0.77	-0.53	0.83	0.72
Total Stockholder Equity	0.91	1.0	0.81	0.84	-0.72	0.89	0.9	1.0	0.05	0.88		0.82	0.79	0.87	0.47	0.98	0.88	0.89	0.35	0.88	0.94	-0.26	0.93	-0.77	0.99	0.74
Accounts Payable	0.88	0.77	0.96	0.83	-0.56	0.61	0.92	0.84	-0.36	0.84	0.82		0.48	0.97	0.59	0.83	0.78	0.98	-0.01	0.83	0.88	0.1	0.66	-0.57	0.76	0.98
Cash	0.67	0.81	0.45	0.58	-0.65	0.85	0.65	0.77	0.34	0.61	0.79	0.48		0.57	0.24	0.78	0.66	0.6	0.38	0.62	0.79	-0.47	0.93	-0.71	0.85	0.38
Non Current Assets Total	0.95	0.83	0.98	0.9	-0.62	0.69	0.98	0.88	-0.17	0.84	0.87	0.97	0.57		0.53	0.87	0.83	1.0	0.11	0.85	0.95	-0.04	0.74	-0.65	0.84	0.94
Non Currrent Assets Other	0.51	0.47	0.55	0.61	-0.14	0.19	0.6	0.55	0.08	0.81	0.47	0.59	0.24	0.53		0.46	0.75	0.55	0.0	0.8	0.49	0.46	0.41	-0.08	0.41	0.45
Net Receivables	0.88	0.98	0.83	0.82	-0.68	0.83	0.89	0.98	-0.03	0.85	0.98	0.83	0.78	0.87	0.46		0.84	0.89	0.27	0.85	0.93	-0.21	0.91	-0.73	0.96	0.77
Non Current Liabilities Total	0.89	0.88	0.79	0.83	-0.64	0.75	0.91	0.92	0.26	0.97	0.88	0.78	0.66	0.83	0.75	0.84		0.83	0.25	0.98	0.88	-0.11	0.82	-0.66	0.86	0.64
Inventory	0.94	0.85	0.97	0.9	-0.63	0.71	0.98	0.9	-0.2	0.86	0.89	0.98	0.6	1.0	0.55	0.89	0.83		0.12	0.86	0.95	-0.03	0.76	-0.66	0.85	0.94
Other Current Assets	0.35	0.38	0.06	0.41	-0.32	0.44	0.22	0.31	0.49	0.13	0.35	-0.01	0.38	0.11	0.0	0.27	0.25	0.12		0.15	0.22	-0.52	0.49	-0.38	0.43	-0.09
Total Liab	0.86	0.88	0.81	0.84	-0.56	0.7	0.9	0.92	0.11	1.0	0.88	0.83	0.62	0.85	0.8	0.85	0.98	0.86	0.15		0.87	0.05	0.79	-0.56	0.85	0.71
Deferred Long Term Liab	0.96	0.92	0.9	0.87	-0.73	0.84	0.97	0.94	0.05	0.86	0.94	0.88	0.79	0.95	0.49	0.93	0.88	0.95	0.22	0.87		-0.24	0.89	-0.78	0.94	0.82
Short Long Term Debt	-0.27	-0.29	0.03	-0.03	0.61	-0.57	-0.11	-0.2	-0.47	0.1	-0.26	0.1	-0.47	-0.04	0.46	-0.21	-0.11	-0.03	-0.52	0.05	-0.24		-0.43	0.74	-0.36	0.13
Total Current Assets	0.85	0.94	0.65	0.77	-0.74	0.9	0.82	0.92	0.27	0.77	0.93	0.66	0.93	0.74	0.41	0.91	0.82	0.76	0.49	0.79	0.89	-0.43		-0.8	0.96	0.55
Short Term Debt	-0.8	-0.78	-0.59	-0.55	0.89	-0.89	-0.69	-0.74	-0.18	-0.53	-0.77	-0.57	-0.71	-0.65	-0.08	-0.73	-0.66	-0.66	-0.38	-0.56	-0.78	0.74	-0.8		-0.81	-0.51
Intangible Assets	0.91	0.99	0.76	0.82	-0.75	0.93	0.88	0.98	0.15	0.83	0.99	0.76	0.85	0.84	0.41	0.96	0.86	0.85	0.43	0.85	0.94	-0.36	0.96	-0.81		0.67
Good Will	0.81	0.68	0.94	0.76	-0.5	0.53	0.85	0.75	-0.5	0.72	0.74	0.98	0.38	0.94	0.45	0.77	0.64	0.94	-0.09	0.71	0.82	0.13	0.55	-0.51	0.67

Click cells to compare fundamentals

Bloomage Biotechnology Account Relationship Matchups

Bloomage Biotechnology fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Liab	62.2M	56.4M	145.9M	186.8M	214.8M	225.6M
Net Tangible Assets	4.1B	4.5B	5.2B	5.8B	6.6B	3.4B
Retained Earnings	1.1B	1.7B	2.2B	2.5B	2.8B	3.0B
Other Assets	30.8M	69.5M	276.0M	279.4M	321.3M	337.4M
Other Stockholder Equity	409.0K	(1.2M)	(11.6K)	(23.9M)	(21.5M)	(20.4M)
Property Plant Equipment	492.6M	658.3M	1.3B	2.3B	2.7B	2.8B
Total Assets	5.7B	7.5B	8.7B	8.5B	9.7B	5.6B
Other Current Liab	173.1M	366.8M	7.8M	5.8M	6.6M	6.3M
Total Current Liabilities	552.9M	1.4B	1.6B	1.2B	1.4B	830.5M
Total Stockholder Equity	5.0B	5.7B	6.6B	6.9B	8.0B	4.6B
Accounts Payable	119.1M	243.5M	848.3M	700.8M	805.9M	846.2M
Cash	1.4B	1.8B	1.6B	1.2B	1.3B	1.4B
Non Current Assets Total	2.1B	3.5B	4.7B	5.3B	6.1B	6.5B
Non Currrent Assets Other	180.6M	445.5M	558.6M	263.6M	303.1M	266.6M
Net Receivables	372.4M	396.6M	448.4M	447.4M	514.5M	391.6M
Non Current Liabilities Total	145.9M	400.8M	354.7M	265.8M	305.7M	191.1M
Inventory	476.8M	709.1M	1.2B	1.1B	1.3B	1.4B
Other Current Assets	650.1M	190.4M	43.2M	40.1M	46.1M	43.8M
Total Liab	698.8M	1.8B	2.0B	1.5B	1.7B	1.0B
Deferred Long Term Liab	6.2M	18.9M	15.6M	31.8M	36.6M	38.5M
Total Current Assets	3.7B	4.0B	4.0B	3.1B	3.6B	3.0B
Intangible Assets	426.7M	467.3M	475.1M	497.0M	571.5M	353.9M
Good Will	74.6M	67.2M	247.2M	251.3M	289.0M	303.4M
Net Invested Capital	5.0B	5.9B	7.0B	7.1B	8.2B	5.2B
Net Working Capital	3.1B	2.6B	2.4B	1.9B	2.2B	2.4B
Property Plant And Equipment Net	1.2B	2.2B	2.8B	3.6B	4.2B	2.3B
Property Plant And Equipment Gross	1.6B	2.7B	2.8B	4.3B	5.0B	2.7B

Currently Active Assets on Macroaxis

F	Ford Motor
GM	General Motors
S	SentinelOne
GOOG	Alphabet Inc Class C
WD	Walker Dunlop

Other Information on Investing in Bloomage Stock

Balance Sheet is a snapshot of the financial position of Bloomage Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Bloomage Biotechnology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bloomage Biotechnology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bloomage currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bloomage Interest Income vs Ebit Analysis

Interest Income vs Ebit

Interest Income vs Ebit Correlation Analysis

Correlation Coefficient

Interest Income

Ebit

Bloomage Biotechnology fundamental ratios Correlations

Bloomage Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bloomage Biotechnology fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Net Tangible Assets
Total Stockholder Equity	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Inventory	+ 1.0	Non Current Assets Total
Total Assets	+ 0.99	Net Tangible Assets
Intangible Assets	+ 0.99	Net Tangible Assets

Short Term Debt	- 0.89	Common Stock
Common Stock	- 0.85	Other Stockholder Equity
Intangible Assets	- 0.81	Short Term Debt
Short Term Debt	- 0.8	Total Current Assets
Short Term Debt	- 0.8	Other Liab
Short Term Debt	- 0.78	Deferred Long Term Liab